Proteomic cancer biomarkers from discovery to approval: it's worth the effort
about
Network-Based Protein Biomarker Discovery PlatformsAdvances in mass spectrometry-based clinical biomarker discoveryNanoparticle Probes for the Detection of Cancer Biomarkers, Cells, and Tissues by FluorescenceEvaluation of a tyrosine kinase peptide microarray for tyrosine kinase inhibitor therapy selection in cancer.Application of cancer-associated glycoforms and glycan-binding probes to an in vitro diagnostic multivariate index assay for precise diagnoses of cancerIntegrating Pharmacoproteomics into Early-Phase Clinical Development: State-of-the-Art, Challenges, and Recommendations.Recent findings from the Human Proteome Project: opening the mass spectrometry toolbox to advance cancer diagnosis, surveillance and treatment.Proteomics in the Assessment of the Therapeutic Response of Antineoplastic Drugs: Strategies and Practical Applications.Direct Assessment of Plasma/Serum Sample Quality for Proteomics Biomarker Investigation.Advances in endometrial cancer protein biomarkers for use in the clinic.Another Round of "Clue" to Uncover the Mystery of Complex Traits.Proteomic Differences in Feline Fibrosarcomas Grown Using Doxorubicin-Sensitive and -Resistant Cell Lines in the Chick Embryo Model.Disposable inkjet-printed electrochemical platform for detection of clinically relevant HER-2 breast cancer biomarker.
P2860
Q26751123-B67E5EE9-292F-4578-B873-2DF534D1B341Q26770004-D25DC811-4595-42F5-BBF2-1DC708BA0031Q33759991-20403781-1C23-4C75-9DC7-E0D1B43D227CQ37538547-8F8A1AEB-D618-4F46-B1DE-D4A537F0B35FQ37565619-FFA5FC17-CD23-4349-B194-8EEF855ACDB0Q37691056-A76E8441-3C41-4BAC-864D-9C7BEAAA6439Q38449763-22FB4DEF-82E7-44A9-8349-6B6ACB647D78Q38748131-998F1219-A6B3-4830-B9D5-6E7EF96D8622Q39413046-C4FA3637-DC9C-40E1-B5EB-F568710B2164Q47355920-F2DE7417-64F9-46BF-B3BC-BF3DCF398BB1Q49693977-B5946827-E246-4A6E-BBB5-6C68DF38B030Q50001909-F3B28C11-C762-47DA-B2E7-4DE62AAE0303Q50055468-448C522D-7789-4E5B-9BA6-767409BF5F80
P2860
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
description
2014 nî lūn-bûn
@nan
2014 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@ast
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@en
type
label
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@ast
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@en
prefLabel
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@ast
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@en
P2860
P1476
Proteomic cancer biomarkers from discovery to approval: it's worth the effort
@en
P2093
Daniel W Chan
P2860
P304
P356
10.1586/14789450.2014.897614
P577
2014-04-01T00:00:00Z